CMAHP, cytidine monophospho-N-acetylneuraminic acid hydroxylase, pseudogene, 8418
N. diseases: 24; N. variants: 74
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Mental Disorders | Mental or Behavioral Dysfunction | 2872 | 2897 | 0.100 | None | 1.000 | 5 | 7 | 2015 | 2019 | ||||
|
phenotype | Behavior and Behavior Mechanisms | Mental Process | 645 | 2093 | 0.100 | None | 1.000 | 3 | 5 | 2018 | 2019 | ||||
|
phenotype | Laboratory Procedure | 717 | 1599 | 0.100 | None | 1.000 | 2 | 5 | 2009 | 2019 | |||||
|
group | Nervous System Diseases; Cardiovascular Diseases | Disease or Syndrome | 1658 | 591 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||
|
phenotype | Laboratory Procedure | 338 | 456 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||
|
phenotype | Laboratory Procedure | 264 | 1463 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Clinical Attribute | 20 | 35 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||
|
phenotype | Finding | 653 | 1206 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
phenotype | Laboratory Procedure | 26 | 36 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||
|
phenotype | Laboratory Procedure | 20 | 35 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||
|
phenotype | Laboratory Procedure | 17 | 25 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||
|
phenotype | Laboratory or Test Result | 401 | 4389 | 0.100 | None | 1.000 | 1 | 56 | 2012 | 2012 | |||||
|
disease | Mental Disorders | Mental or Behavioral Dysfunction | 1183 | 839 | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||
|
phenotype | Organism Attribute | 1903 | 3972 | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||
|
disease | Cardiovascular Diseases | Disease or Syndrome | 1576 | 1178 | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2012 | ||||
|
group | Mental Disorders | Mental or Behavioral Dysfunction | 168 | 379 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||
|
group | Nutritional and Metabolic Diseases | Disease or Syndrome | 945 | 50 | 0.010 | None | 1.000 | 1 | 2015 | 2015 | |||||
|
group | Neoplasms | Neoplastic Process | 8221 | 1374 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | |||||
|
group | Neoplasms | Neoplastic Process | 8621 | 1641 | 0.010 | None | 1.000 | 1 | 2019 | 2019 | |||||
|
phenotype | Neoplastic Process | 6626 | 169 | 0.010 | None | 1.000 | 1 | 2016 | 2016 | ||||||
|
disease | Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases | Disease or Syndrome | 375 | 170 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | |||||
|
disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | Neoplastic Process | 288 | 4 | 0.010 | None | 1.000 | 1 | 2013 | 2013 | |||||
|
disease | Neoplasms | Neoplastic Process | 3111 | 6892 | 0.010 | None | 1.000 | 1 | 2013 | 2013 | |||||
|
disease | Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | Disease or Syndrome | 939 | 584 | 0.010 | None | 1.000 | 1 | 2019 | 2019 |